0000899243-20-009026.txt : 20200319 0000899243-20-009026.hdr.sgml : 20200319 20200319174807 ACCESSION NUMBER: 0000899243-20-009026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200317 FILED AS OF DATE: 20200319 DATE AS OF CHANGE: 20200319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEISTER PAUL M CENTRAL INDEX KEY: 0001033876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 20729659 MAIL ADDRESS: STREET 1: 18 SHIP ROCK ROAD CITY: NORTH HAMPTON STATE: NH ZIP: 03862 FORMER NAME: FORMER CONFORMED NAME: Meister Paul M. DATE OF NAME CHANGE: 20150730 FORMER NAME: FORMER CONFORMED NAME: MEISTER PAUL M DATE OF NAME CHANGE: 19970215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-17 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001033876 MEISTER PAUL M C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD, 3RD FLOOR BRIDGEWATER NJ 08807 1 0 0 0 Class A Common Stock 2020-03-17 4 P 0 149439 2.79 A 149439 D Class A Common Stock 2020-03-18 4 P 0 204210 2.71 A 353649 D The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.72 to $2.85, inclusive. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.555 to $2.85, inclusive. The reporting person undertakes to provide, upon request by the staff of the SEC, the Issuer, or a security holder of the Issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Exhibit 24 - Power of Attorney /s/ Meredith Cook, Attorney-in-Fact 2020-03-19 EX-24 2 attachment1.htm EX-24 DOCUMENT
                               POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby constitutes and
appoints each of (i) the General Counsel of Amneal Pharmaceuticals, Inc., a
Delaware corporation (the "Company") and who is currently Stephen Manzano, (ii)
the Company's Chief Financial Officer, who is currently Todd P. Branning, (iii)
the Company's Vice President, Transactions - Legal, who is currently Meredith
Cook, and (iv) the Company's Chief Human Resources Officer, who is currently
Nikita Shah, and their respective successors (including anyone serving in such
capacities on an interim or acting basis), signing singly, with full powers of
substitution, as the undersigned's true and lawful attorney-in-fact to:

     1.   prepare, execute in the undersigned's name and on the
          undersigned's behalf, and submit to the U.S. Securities and Exchange
          Commission (the "SEC") a Form ID, including amendments thereto, and
          any other documents necessary or appropriate to obtain codes and
          passwords enabling the undersigned to make electronic filings with the
          SEC of reports required by Section 16(a) of the Securities Exchange
          Act of 1934 or any rule or regulation of the SEC;

     2.   execute for and on behalf of the undersigned, in the undersigned's
          capacity as an officer and/or director of the Company, and/or 10%
          holder of the Company's capital stock, Forms 3, 4, and 5 and any
          amendments thereto in accordance with Section 16(a) of the Securities
          Exchange Act of 1934 and the rules thereunder;

     3.   do and perform any and all acts for and on behalf of the
          undersigned which may be necessary or desirable to complete and
          execute any such Form 3, 4, or 5, complete and execute any amendment
          or amendments thereto, and timely file such form with the SEC and any
          stock exchange or similar authority; and

     4.   take any other action of any type whatsoever in connection with
          the foregoing which, in the opinion of such attorney-in-fact, may be
          of benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such attorney-in-
          fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

          This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

           IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 20th day of February, 2020.

                                   /s/ Paul Meister
                                   -----------------------------------
                                   By: Paul Meister